Skip to Content

RDY 613 (Pramipexole Dihydrochloride Extended-Release 1.5 mg)

Pill with imprint RDY 613 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 1.5 mg. It is supplied by Dr. Reddy's Laboratories Limited.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 613

Pramipexole dihydrochloride extended-release 1.5 mg RDY 613

Pramipexole Dihydrochloride Extended-Release

Imprint:
RDY 613
Strength:
1.5 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy's Laboratories Limited
National Drug Code (NDC):
55111-0613

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide